Further evidence for the presence of 'Septide-Sensitive'' tachykinin binding sites in tissues possessing solely NK1 tachykinin receptors

Biochemical and Biophysical Research Communications

Volumn 270, Issue 2, 2000, Pages 668-672

  Torrens, Yvette ^a   Beaujouan, Jean Claude ^a   Saffroy, Monique ^a   Glowinski, Jacques ^a  

^a l'alimentation et l'Environnement   (France)

Author keywords

Astrocyte; cAMP; CHO cells; IPs; NK1; Septide; U373MG cells; 125I NKA binding

Indexed keywords

COMPLEMENTARY DNA; NEUROKININ 1 RECEPTOR; NEUROKININ A; SEPTIDE;

ANIMAL CELL; ARTICLE; ASTROCYTE; BINDING SITE; CHO CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALIA; IPS;

EID: 0034643287     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2000.2477     Document Type: Article

References (18)

1. Maggi C. A. The mammalian tachykinin receptors. Gen. Pharmacol. 26:1995;911-944.
2. Fong T., Yu H., Strader C. Molecular basis for the species selectivity of the neurokinin-1 receptor antagonists CP-96,345 and RP67580. J. Biol. Chem. 267:1992;25668-25671.
3. Petitet F., Saffroy M., Torrens Y., Lavielle S., Chassaing G., Loeuillet D., Glowinski J., Beaujouan J-C. Possible existence of a new tachykinin receptor subtype in the guinea-pig ileum. Peptides. 13:1992;383-388.
4. Hall J., Mitchell D., Morton I. K. M. Typical and atypical NK1 tachykinin receptor characteristics in the rabbit isolated iris sphincter. Br. J. Pharmacol. 112:1994;985-991.
5. Torrens Y., Saffroy M., Glowinski J., Beaujouan J-C. Substance P(6-11) and natural tachykinins interact with septide-sensitive tachykinin receptors coupled to a phospholipase C in the rat urinary bladder. Neuropeptides. 31:1997;243-251.
6. 11]substance P(7-11), a triatiated septide-like peptide, in chinese hamster ovary cells expressing human neurokinin-1 receptors and in rat submandibular glands. Mol. Pharmacol. 52:1997;120-127.
7. Beaujouan J-C., Saffroy M., Torrens Y., Sagan S., Glowinski J. Pharmacological characterization of tachykinin septide-sensitive binding sites in the rat submaxillary gland. Peptides. 20:1999;1347-1352.
8. Glowinski J. The "septide-sensitive" tachykinin receptor: Still an enigma. TIPS. 16:1995;365-367.
9. Maggi C. A., Schwartz T. W. The dual nature of the tachykinin NK1 receptor. TIPS. 18:1997;351-355.
10. Beaujouan J-C., Teutsch B., Saffroy M., Petitet F., Torrens Y., Glowinski J. NK-1 receptors are the only class of tachykinin receptors found on mouse cortical astrocytes. Peptides. 12:1991;813-819.
11. Heuillet E., Ménager J., Fardin V., Flamand O., Bock M., Garret C., Crespo A., Fallourd A. M., Doble A. Characterization of a human NK1 tachykinin receptor in the astrocytoma cell line U373 MG. J. Neurochem. 60:1993;868-876.
12. Beaujouan J-C., Torrens Y., Viger A., Glowinski J. A new type of tachykinin binding site in the rat brain characterized by specific binding of a labeled eledoisin derivative. Mol. Pharmacol. 26:1984;248-254.
13. Hermans E., Jeanjean A., Fardin V., Pradier L., Garret C., Laduron P., Octave J-N., Maloteaux J-M. Interaction of the substance P receptor antagonist RP 67580 with the rat brain NK1 receptor expressed in transfected CHO cells. Eur. J. Pharmacol. 245:1993;43-50.
14. Bradford M. A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
15. Torrens Y., Daguet De Montety M-C., El Etr M., Beaujouan J-C., Glowinski J. Tachykinin receptors of the NK1 type (substance P) coupled positively to phospholipase C on cortical astrocytes from the newborn mouse in primary culture. J. Neurochem. 52:1989;1913-1918.
16. Sagan S., Chassaing G., Pradier L., Lavielle S. Tachykinin peptides affect differently the second messenger pathways after binding to CHO-expressed human NK-1 receptors. J.P.E.T. 278:1996;1039-1048.
17. Pradier L., Ménager J., Le Guern J., Bock M-D., Heuillet E., Fardin V., Garret C., Doble A., Mayaux J-F. Septide: An agonist for the NK1 receptor acting at a site distinct form substance P. Mol. Pharmacol. 45:1994;287-293.
18. Ciucci A., Palma C., Manzini S., Werge T. M. Point mutation increases a form of the NK1 receptor with high affinity for neurokinin A and B and septide. Br. J. Pharmacol. 125:1998;393-401.